Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR
Marketer
Zyphar's Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (1000mg) + Pioglitazone (15mg)
Overview Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (1 mg/1000 mg/15 mg) manage blood glucose in adults with type 2 diabetes. This combination therapy complements diet and exercise to enhance glycemic control. It improves insulin efficiency, reducing blood sugar. Follow your physician's prescribed dosage and regimen; take with food to minimize gastrointestinal distress. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Overdosage risks hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function tests are conducted prior to treatment commencement. Limit alcohol consumption as it may intensify side effects.
Uses of Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR whole; do not crush, chew, or fracture it. Administer this extended-release tablet with food.
Common Side effects of Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
How Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR works:
Glimfirst MP Forte (1 mg/1000 mg/15 mg sustained-release tablets) combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin sensitivity. Finally, pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glimfirst MP Forte 1 mg/1000 mg/15 mg SR Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimfirst MP Forte 1 mg/1000 mg/15 mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimfirst MP Forte 1 mg/1000 mg/15 mg tablet is likely not suitable for use while breastfeeding. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is a possibility if your blood glucose level is either elevated or depressed. Refrain from driving should these conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR :
Should you forget a dose of Glimfirst MP Forte 1 mg/1000 mg/15 mg sustained-release tablets, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimfirst MP Forte 1 mg/1000 mg/15 mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently